Rash with fever resident survival guide: Difference between revisions
Agnesrinky (talk | contribs) |
Agnesrinky (talk | contribs) |
||
(71 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
__NOTOC__ | |||
{| class="infobox" style="margin: 0 0 0 0; border: 0; float: right; width: 100px; background: #A8A8A8; position: fixed; top: 250px; right: 21px; border-radius: 0 0 10px 10px;" cellpadding="0" cellspacing="0" ; | |||
|- | |||
! style="padding: 0 5px; font-size: 85%; background: #A8A8A8" align="center" |{{fontcolor|#2B3B44|Rash with fever Resident Survival Guide Microchapters}} | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Rash with fever resident survival guide#Overview|Overview]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Rash with fever resident survival guide#Causes|Causes]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Rash with fever resident survival guide#Diagnosis|Diagnosis]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Rash with fever resident survival guide#Treatment|Treatment]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Rash with fever resident survival guide#Do's|Do's]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Rash with fever resident survival guide#Don'ts|Don'ts]] | |||
|} | |||
{{WikiDoc CMG}}; {{AE}} {{RAB}} | {{WikiDoc CMG}}; {{AE}} {{RAB}} | ||
{{SK}} | {{SK}} Approach to febrile rash, Approach to Rash | ||
==Overview== | ==Overview== | ||
A patient with [[fever]] may often come with [[rash]].There are several causes for [[rash]] in [[febrile]] patients.[[Rash]] caused by infectious agents may have mild to severe outcome,so it is very important to diagnose the cause and treat accordingly.There can be some non-infectious causes as well.To diagnose efficiently a complete history must be taken which includes history of recent travel, contact with animals, [[medications]], and exposure to forests and other natural environments. Additionally, time of onset of symptoms and morphology, location, distribution of the [[rash]] are be helpful in the clinical diagnosis.The most common causes are [[Dengue hemorrhagic fever]], [[Rocky Mountain spotted fever]] [[Rocky Mountain spotted fever|(RMSF]]), [[Scarlet fever]], [[Toxic Epidermal Necrolysis]] ([[Toxic epidermal necrolysis|TEN]]),[[Stevens-Johnson Syndrome]] ([[Stevens-Johnson syndrome|SJS)]], [[Henoch-Schonlein Purpura]] ([[Henoch-Schönlein purpura|HSP]]), [[Kawasaki disease]], [[Lyme disease]], [[Endocarditis]], [[Disseminated gonococcal infection]],[[Autoimmune vasculitis]], [[Systemic lupus erythematosus]] ([[SLE]]),[[Rheumatoid arthritis]],[[Sjogren’s syndrome]], [[Varicella]], [[Necrotizing fasciitis]], [[Rubella]], [[Measles]].Usually,skin rashes are nonspecific and self-limited.If it is caused by viral infections unlike bacterial infections, they do not respond to [[Antibiotic|antibiotics]], so treatment usually focuses on relieving symptoms.If it is caused by [[bacterial infection]] specific [[antibiotic]] is prescribed.The treatment of [[non-infectious]] [[rashes]] depend on the underlying cause. | |||
==Causes== | ==Causes== | ||
===Life Threatening Causes=== | ===Life Threatening Causes=== | ||
Life-threatening causes of febrile rashes include conditions that may result in death or permanent disability within 24 hours if left untreated. | Life-threatening causes of febrile rashes include conditions that may result in death or permanent disability within 24 hours if left untreated.<ref name="pmid26483989">{{cite journal |vauthors=Kang JH |title=Febrile Illness with Skin Rashes |journal=Infect Chemother |volume=47 |issue=3 |pages=155–66 |date=September 2015 |pmid=26483989 |pmc=4607768 |doi=10.3947/ic.2015.47.3.155 |url= |issn=}}</ref> | ||
* [[Meningococcemia]] or [[Meningoencephalitis]] | |||
*[[Thrombotic Thrombocytopenic Purpura]] (TTP) | *[[Meningococcemia]] or [[Meningoencephalitis]] | ||
*[[Disseminated Intravascular Coagulation]] (DIC) | *[[Thrombotic Thrombocytopenic Purpura]] [[Thrombotic thrombocytopenic purpura|(TTP]]) | ||
* Bacterial [[sepsis]]( | *[[Disseminated Intravascular Coagulation]] ([[Disseminated intravascular coagulation|DIC]]) | ||
*Bacterial [[sepsis]]([[Streptococcus pneumoniae|Pneumococca]]<nowiki/>l, [[Staphylococcus|Staphylococcal]]) | |||
===Common Causes=== | ===Common Causes=== | ||
Common causes of rash with fever are given below<ref name="pmid26483989">{{cite journal |vauthors=Kang JH |title=Febrile Illness with Skin Rashes |journal=Infect Chemother |volume=47 |issue=3 |pages=155–66 |date=September 2015 |pmid=26483989 |pmc=4607768 |doi=10.3947/ic.2015.47.3.155 |url= |issn=}}</ref> | Common causes of rash with fever are given below :<ref name="pmid26483989">{{cite journal |vauthors=Kang JH |title=Febrile Illness with Skin Rashes |journal=Infect Chemother |volume=47 |issue=3 |pages=155–66 |date=September 2015 |pmid=26483989 |pmc=4607768 |doi=10.3947/ic.2015.47.3.155 |url= |issn=}}</ref> | ||
*[[Typhoid fever]] | *[[Typhoid fever]] | ||
*[[Dengue hemorrhagic fever]] | *[[Dengue hemorrhagic fever]] | ||
*[[Rocky Mountain spotted fever|Rocky Mountain spotted feve]]<nowiki/>r (RMSF) | *[[Rocky Mountain spotted fever|Rocky Mountain spotted feve]]<nowiki/>r ([[Rocky Mountain spotted fever|RMSF]]) | ||
*[[Scarlet fever]] | *[[Scarlet fever]] | ||
*[[Toxic epidermal necrolysis|Toxic Epidermal Necrolysis]] (TEN) | *[[Toxic epidermal necrolysis|Toxic Epidermal Necrolysis]] ([[Toxic epidermal necrolysis|TEN]]) | ||
*[[Stevens-Johnson syndrome|Stevens-Johnson Syndrome]] (SJS) | *[[Stevens-Johnson syndrome|Stevens-Johnson Syndrome]] ([[Stevens-Johnson syndrome|SJS]]) | ||
*[[Henoch-Schönlein purpura|Henoch-Schonlein Purpura]] (HSP) | *[[Henoch-Schönlein purpura|Henoch-Schonlein Purpura]] (HSP) | ||
*[[Kawasaki disease]] | *[[Kawasaki disease]] | ||
Line 29: | Line 48: | ||
*[[Endocarditis]] | *[[Endocarditis]] | ||
*[[Disseminated gonococcal infection]] | *[[Disseminated gonococcal infection]] | ||
* Autoimmune [[vasculitis]] | *Autoimmune [[vasculitis]] | ||
**[[Systemic lupus erythematosus]] (SLE) | **[[Systemic lupus erythematosus]] ([[SLE]]) | ||
**[[Rheumatoid arthritis]] | **[[Rheumatoid arthritis]] | ||
**[[Sjögren's syndrome|Sjogren’s syndrome]] | **[[Sjögren's syndrome|Sjogren’s syndrome]] | ||
Line 42: | Line 61: | ||
==Diagnosis== | ==Diagnosis== | ||
Shown below are 04 algorithms summarizing the diagnosis of [[Rash]] with [[fever]] in a patient: | Shown below are 04 algorithms summarizing the diagnosis of [[Rash]] with [[fever]] in a patient:<ref name="Murphy-LavoieLeGros2018">{{cite journal|last1=Murphy-Lavoie|first1=Heather|last2=LeGros|first2=Tracy|title=The Algorithmic Approach to the Unidentified Rash|year=2018|pages=1–5|doi=10.1007/978-3-319-75623-3_1}}</ref><ref name="pmid26483989">{{cite journal |vauthors=Kang JH |title=Febrile Illness with Skin Rashes |journal=Infect Chemother |volume=47 |issue=3 |pages=155–66 |date=September 2015 |pmid=26483989 |pmc=4607768 |doi=10.3947/ic.2015.47.3.155 |url= |issn=}}</ref> | ||
<span style="font-size:85%">'''Abbreviations:''' BP: Blood pressure, '''RR'''=Respiratory rate, '''HR'''=Heart Rate, '''HIV'''=[[Human Immunodeficiency Virus (HIV)|Human immunodeficiency Virus]], '''EM major'''=[[Erythema multiforme|Erythema Multiforme Major]], '''EM minor'''=Erythema Multiforme Minor, '''H/O'''=History of, '''DIC'''=[[disseminated intravascular coagulation]], '''VZV'''=[[Varicella zoster virus]],'''SLE'''=[[Systemic lupus erythematosus]], [[Thrombotic Thrombocytopenic Purpura|TTP=Thrombotic Thrombocytopenic Purpura]] ,RMSF= [[Rocky Mountain spotted fever|Rocky Mountain spotted feve]]<nowiki/>r, '''IM'''=Intramuscular, '''IVIG'''= [[Intravenous immunoglobulin|Intravenous Immunoglobulin]], '''IVDU''' -Intravenous Drug User | |||
<br /> | |||
{{Family tree/start}} | {{Family tree/start}} | ||
{{Family tree | | | | | | | A01 | | | |A01=Patient with [[Fever]] and [[Rash]]}} | {{Family tree | | | | | | | | | A01 | | | |A01=Patient with [[Fever]] and [[Rash]]}} | ||
{{Family tree | | | | | | | | | {{Family tree | | | | | | | | | |!| | | }} | ||
{{Family tree | | | | | | | B01 | | | |B01= Take complete history}} | {{Family tree | | | | | | | | | B01 | | | |B01= Take complete history}} | ||
{{Family tree | | | | | | | | | {{Family tree | | | | | | | | | |!| | | }} | ||
{{familytree/start |summary=Sample 10}}{{familytree/start |summary=PE diagnosis Algorithm.}} | {{familytree/start |summary=Sample 10}}{{familytree/start |summary=PE diagnosis Algorithm.}} | ||
{{Family tree/start}} | {{Family tree/start}} | ||
{{Family tree | | | | | | | B02 | | | |B02=<div style="float: left; text-align: left; height: | {{Family tree | | | | | | | | | B02 | | | |B02=<div style="float: left; text-align: left; height: 20em; width: 20em; padding:1em;"> '''Record [[Vital sign]]s:'''<br> | ||
---- | ---- | ||
❑ Measure the [[temperature]] <br> | ❑ Measure the [[temperature]] <br><br>❑ Record [[Pulse]] rate <br><br>❑ Record [[Blood pressure]]<br><br> | ||
❑ Record Respiratory rate<br><br></div>}} | |||
{{Family tree | | | | | | | | | {{Family tree | | | | | | | | | |!| | | }} | ||
{{familytree/start |summary=Sample 10}}{{familytree/start |summary=PE diagnosis Algorithm.}} | {{familytree/start |summary=Sample 10}}{{familytree/start |summary=PE diagnosis Algorithm.}} | ||
{{Family tree/start}} | {{Family tree/start}} | ||
{{Family tree | | | | | | | B02 | | | |B02=<div style="float: left; text-align: left; height: | {{Family tree | | | | | | | | | B02 | | | |B02=<div style="float: left; text-align: left; height: 25em; width: 20em; padding:1em;"> '''Ask about associated symptoms:'''<br> | ||
---- | ---- | ||
❑ [[Vomiting]] <br>❑ [[Nausea]]<br> ❑ Abdominal Pain <br> ❑ [[Cough]]<br> ❑ [[Sore throat]] <br> ❑ [[Chest pain]] <br> ❑[[ | ❑ [[Vomiting]] <br><br>❑ [[Nausea]]<br><br> ❑ [[Abdominal Pain]] <br><br> ❑ [[Cough]]<br><br> ❑ [[Sore throat]] <br><br> ❑ [[Chest pain]] <br><br> ❑ [[Arthralgia]]<br><br> </div>}} | ||
{{Family tree | | | | | | | | | {{Family tree | | | | | | | | | |!| | | }} | ||
{{familytree/start |summary=Sample 10}}{{familytree/start |summary=PE diagnosis Algorithm.}} | {{familytree/start |summary=Sample 10}}{{familytree/start |summary=PE diagnosis Algorithm.}} | ||
{{Family tree/start}} | {{Family tree/start}} | ||
{{Family tree | | | | | | | B02 | | | |B02=<div style="float: left; text-align: left; height: | {{Family tree | | | | | | | | | B02 | | | |B02=<div style="float: left; text-align: left; height: 40em; width: 20em; padding:1em;"> '''Ask about other medical history:'''<br> | ||
---- | ---- | ||
❑ [[Asplenia]]<br> ❑ Infection or [[Inflammation]]<br> | ❑ [[Asplenia]]<br><br> ❑ [[Infection]] or [[Inflammation]]<br><br> | ||
❑[[Sarcoid]] <br> ❑ [[Malignancy]] <br> ❑ [[Collagen vascular disease]] <br> | ❑ [[Sarcoid]] <br><br> ❑ [[Malignancy]] <br><br> ❑ [[Collagen vascular disease]] <br><br>❑ Any recent [[medication]]s<br><br>❑ [[Valvular heart disease]]<br><br>❑ [[Chronic liver disease]]<br><br>❑ Solid organ or bone marrow [[transplantation]]<br><br> ❑ [[Steroid]] use<br> <br>❑ [[Chemotherapy]] related immune suppression<br><br></div>}} | ||
{{Family tree | | | | | | | | | {{Family tree | | | | | | | | | |!| | | }} | ||
{{familytree/start |summary=Sample 10}}{{familytree/start |summary=PE diagnosis Algorithm.}} | {{familytree/start |summary=Sample 10}}{{familytree/start |summary=PE diagnosis Algorithm.}} | ||
{{Family tree/start}} | {{Family tree/start}} | ||
{{Family tree | | | | | | | B02 | | | |B02=<div style="float: left; text-align: left; height: | {{Family tree | | | | | | | | | B02 | | | |B02=<div style="float: left; text-align: left; height: 30em; width: 20em; padding:1em;"> '''Ask about recent Exposure:'''<br> | ||
---- | ---- | ||
❑ Communal living<br><br> ❑ [[Tick]] exposure <br><br> ❑ Dog exposure <br><br> ❑ Salt water exposure <br><br> ❑ [[Tampon]] use <br><br> ❑ [[IVDU]] <br><br> ❑ [[Trauma]] and [[Diabetes Mellitus]]<br> <br>❑ Exposure to [[sexually transmitted disease]], including risk factors for infection with [[human immunodeficiency virus]] (HIV)<br><br></div>}} | |||
{{Family tree | | | | | | | | | {{Family tree | | | | | | | | | |!| | | }} | ||
{{familytree/start |summary=Sample 10}}{{familytree/start |summary=PE diagnosis Algorithm.}} | {{familytree/start |summary=Sample 10}}{{familytree/start |summary=PE diagnosis Algorithm.}} | ||
{{Family tree/start}} | {{Family tree/start}} | ||
{{Family tree | | | | | | | B02 | | | |B02=<div style="float: left; text-align: left; height: | {{Family tree | | | | | | | | | B02 | | | |B02=<div style="float: left; text-align: left; height: 30em; width: 20em; padding:1em;"> '''Ask about recent travel history:'''<br> | ||
---- | ---- | ||
❑ International Travel history<br> | ❑ International Travel history<br><br>❑ Travel in the mid-Atlantic, central, western, | ||
and northeastern parts of the United States(Lyme disease is common) <br> | and northeastern parts of the United States([[Lyme disease]] is common) <br><br>❑ Travel in wooded areas([[Rocky Mountain spotted fever]] and [[tick]]-borne diseases are common)<br><br>❑ Recent camping history<br><br></div>}} | ||
{{Family tree | | | | | | | | | |!| | | }} | |||
</div>}} | |||
{{Family tree | | | | | | | | | |||
{{familytree/start |summary=Sample 10}}{{familytree/start |summary=PE diagnosis Algorithm.}} | {{familytree/start |summary=Sample 10}}{{familytree/start |summary=PE diagnosis Algorithm.}} | ||
{{Family tree/start}} | {{Family tree/start}} | ||
{{Family tree | | | | | | | B02 | | | |B02=<div style="float: left; text-align: left; height: | {{Family tree | | | | | | | B02 | | | |B02=<div style="float: left; text-align: left; height: 40em; width: 22em; padding:1em;"> '''General Physical Examination:'''<br> | ||
---- | ---- | ||
❑ General appearance-Is the patient [[toxic]]? or normal appearance<br><br>❑ Look for new-onset heart [[murmur]] or [[nuchal rigidity]] <br><br>❑ [[Nuchal rigidity]]<br><br>❑ Palpate [[Lymph nodes]] for Generalized [[lymphadenopathy]]<br><br>❑ [[Conjunctival injection]]<br><br>❑ Look for [[Nikolsky sign]]:[[Sloughing]] of full-thickness skin with lateral pressure<br><br>❑ Look for any [[lesion]] on the back, buttocks, or [[perineum]]<br><br>❑ In diabetic patients check feet <br><br>❑ Palpate abdomen for [[hepatosplenomegaly]]</div>}} | |||
{{Family tree | | | | | | | |!| | | | | }} | {{Family tree | | | | | | | |!| | | | | }} | ||
{{Family tree | | | | | | | C03 | |C03=Characterize [[rash]]}} | {{Family tree | | | | | | | C03 | |C03=Characterize [[rash]]}} | ||
{{Family tree | | |,|-|-|-|-|+|-|-|-|v|-|-|-|-|-|.|}} | {{Family tree | | |,|-|-|-|-|+|-|-|-|v|-|-|-|-|-|.|}} | ||
{{Family tree | | |!| | | | |!| | | |!| | | | | |!|}} | {{Family tree | | |!| | | | |!| | | |!| | | | | |!|}} | ||
{{Family tree | | p09 | | |o09| | |u09| | | |s09| |p09=[[Maculopapular]] rash|o09=[[Petechial]]/[[Purpuric]] rash|u09=[[Vesiculobullous]] rash|s09=[[Erythematous]] rash }} | {{Family tree | | p09 | | |o09| | |u09| | | |s09| |p09=[[Maculopapular]] [[rash]]|o09=[[Petechial]]/[[Purpuric]] [[rash]]|u09=[[Vesiculobullous]] [[rash]]|s09=[[Erythematous]] [[rash]] }} | ||
{{familytree/end}} | {{familytree/end}} | ||
Line 99: | Line 121: | ||
'''<big>Terminolgies used to diagnose Rashes</big>''' | '''<big>Terminolgies used to diagnose Rashes</big>'''<ref name="pmid26483989">{{cite journal |vauthors=Kang JH |title=Febrile Illness with Skin Rashes |journal=Infect Chemother |volume=47 |issue=3 |pages=155–66 |date=September 2015 |pmid=26483989 |pmc=4607768 |doi=10.3947/ic.2015.47.3.155 |url= |issn=}}</ref> | ||
{| style="border: 2px solid #4479BA; align="left" | {| style="border: 2px solid #4479BA; align=" left" | ||
! style="width: Phenotype Domains; background: #4479BA;" | {{fontcolor|#FFF|Term}} | ! style="width: Phenotype Domains; background: #4479BA;" |{{fontcolor|#FFF|Term}} | ||
! style="width: Clinical Features; background: #4479BA;" | {{fontcolor|#FFF|Clinical Features}} | ! style="width: Clinical Features; background: #4479BA;" |{{fontcolor|#FFF|Clinical Features}} | ||
|- | |- | ||
|- | |- | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | '''<big>Lesion</big>''' | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |'''<big>Lesion</big>''' | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Single,Small affected area | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |Single,Small affected area | ||
|- | |- | ||
|- | |- | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | '''<big>Rash</big>''' | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |'''<big>Rash</big>''' | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |An [[eruption]] on the skin; more extensive than a single lesion | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |An [[eruption]] on the skin; more extensive than a single lesion | ||
|- | |- | ||
|- | |- | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | '''<big>Macule</big>''' | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |'''<big>Macule</big>''' | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Well circumscribed area of change without elevation | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |Well circumscribed area of change without elevation | ||
|- | |- | ||
|- | |- | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | '''<big>[[Papule]]</big>''' | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |'''<big>[[Papule]]</big>''' | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Solid raised lesion ≤1 cm | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |Solid raised lesion ≤1 cm | ||
|- | |- | ||
|- | |- | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | '''<big>[[Petechia]]</big>''' | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |'''<big>[[Petechia]]</big>''' | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |Small red/brown [[macule]] ≤1 cm | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |Small red/brown [[macule]] ≤1 cm | ||
that does not blanche | that does not blanche | ||
|- | |- | ||
|- | |- | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | '''<big>[[Purpura]]</big>''' | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |'''<big>[[Purpura]]</big>''' | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |[[Hemorrhagic]] area > 3 mm that does not [[blanch]] | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |[[Hemorrhagic]] area > 3 mm that does not [[blanch]] | ||
|- | |- | ||
|- | |- | ||
Line 139: | Line 161: | ||
If a patient present with fever with [[maculopapular]] [[rash]] then follow the algorithm given below: | If a patient present with fever with [[maculopapular]] [[rash]] then follow the algorithm given below:<ref name="Murphy-LavoieLeGros2018">{{cite journal|last1=Murphy-Lavoie|first1=Heather|last2=LeGros|first2=Tracy|title=The Algorithmic Approach to the Unidentified Rash|year=2018|pages=1–5|doi=10.1007/978-3-319-75623-3_1}}</ref> | ||
Line 147: | Line 169: | ||
{{Family tree | | | | | | | A01 | | | |A01=[[Fever]] with [[maculopapular]] rash}} | {{Family tree | | | | | | | A01 | | | |A01=[[Fever]] with [[maculopapular]] rash}} | ||
{{Family tree | | | | | | | |!| | | | | }} | {{Family tree | | | | | | | |!| | | | | }} | ||
{{Family tree | | | | | | | B01 | | | |B01= Look at the rash and it's distribution}} | {{Family tree | | | | | | | B01 | | | |B01= Look at the [[rash]] and it's distribution}} | ||
{{Family tree | | | | | | | |!| | | | | }} | {{Family tree | | | | | | | |!| | | | | }} | ||
{{Family tree | | | | | | | |!| | | | | }} | {{Family tree | | | | | | | |!| | | | | }} | ||
Line 154: | Line 176: | ||
{{Family tree | | | C03 | | | | | | C04 |C03= Central distribution with fever|C04=Peripheral distribution with [[fever]]}} | {{Family tree | | | C03 | | | | | | C04 |C03= Central distribution with fever|C04=Peripheral distribution with [[fever]]}} | ||
{{Family tree | | | |!| | | | | | | |!| }} | {{Family tree | | | |!| | | | | | | |!| }} | ||
{{Family tree | | | D04 | | | | | | R08 |D04=❑Viral [[exanthem]]<br> ❑[[Lyme]] | {{Family tree | | | D04 | | | | | | R08 |D04=❑Viral [[exanthem]]<br> ❑[[Lyme]] disease<br>❑[[Still's Disease|Still disease]]|R08=Look for target lesion}} | ||
{{Family tree | | | | | | | | | | | |!| }} | {{Family tree | | | | | | | | | | | |!| }} | ||
{{Family tree | | | | | | | |,|-|-|-|^|-|-|-|-|-|-|-|-|-|.|}} | {{Family tree | | | | | | | |,|-|-|-|^|-|-|-|-|-|-|-|-|-|.|}} | ||
Line 162: | Line 184: | ||
{{Family tree | | | | | |p09| |o09| | | | | | |l09| |!| | | |p09=[[Stevens-Johnson Syndrome]]|o09=[[Erythema Multiforme]]|l09=[[Lyme disease]]}} | {{Family tree | | | | | |p09| |o09| | | | | | |l09| |!| | | |p09=[[Stevens-Johnson Syndrome]]|o09=[[Erythema Multiforme]]|l09=[[Lyme disease]]}} | ||
{{Family tree | | | | | |!| | | | |!| | | | | | | |!| | | |!| | | | | | |}} | {{Family tree | | | | | |!| | | | |!| | | | | | | |!| | | |!| | | | | | |}} | ||
{{Family tree | | | | | |P08| | |P09| | | | | |p07| |!| | | | | |P08=<div style="float: left; text-align: left; height: | {{Family tree | | | | | |P08| | |P09| | | | | |p07| |!| | | | | |P08=<div style="float: left; text-align: left; height: 32em; width: 14em; padding:1em;"> '''Characteristics:'''<br> | ||
---- | ---- | ||
❑ Usually | ❑ Usually occurs due to drug reaction <br><br/> ❑ Diffusely distributed target lesions including the palms and soles<br/><br/>❑ [[Mucous membrane]] may be involved<br/><br/> ❑ [[Toxic]] appearing patient<br/><br/> ❑ [[Fever]] <br><br/> </div>|P09=<div style="float: left; text-align: left; height: 46em; width: 14em; padding:1em;"> '''Characteristics:'''<br> | ||
---- | ---- | ||
❑ Usually autoimmune <br> | ❑ Usually [[autoimmune]] <br><br/> ❑ May follow [[Herpes simplex]], [[Mycoplasma]], [[Fungal]] diseases or may occur due to drug exposure ([[sulfa drugs]], [[anticonvulsants]], [[antibiotics]])<br/>❑ [[Mucous membrane]] not involved in '''EM minor'''<br/><br/> ❑ In '''EM major''' significant involvement of [[mucous membrane]]<br/><br/> ❑ Nonspecific [[upper respiratory tract infection]], moderate [[fever]], general discomfort, [[cough]], [[sore throat]], [[vomiting]], [[chest pain]], [[diarrhoea]] may occur before the onset of [[rash]]<br/><br/> ❑ [[Rash]] may be seen in the palms, soles, face, and [[extensor]] surfaces and eye involvement in 10% </div>|p07=<div style="float: left; text-align: left; height: 36em; width: 14em; padding:1em;"> '''Characteristics:'''<br> | ||
---- | ---- | ||
❑ Usually there is a history of travelling to wooden area <br> | ❑ Usually there is a history of travelling to wooden area <br><br/> ❑ [[Tick-born disease|Tick-borne]] illness is caused by [[Borrelia burgdorferi]]<br/><br/>❑ A big lesion with dark red border and central clearing known as [[Erythema migrans]]<br/><br/> ❑ Migratory [[arthalgia]] <br/><br/> ❑ [[Atrioventricular]] [[Nodal block]]<br/><br/> ❑ [[Myalgia]]<br/><br/> ❑ [[Fever]]<br/><br/> ❑ [[Bells palsy]]<br/><br/> ❑ Confusion<br/><br/> ❑ [[Meningitis]] </div>}} | ||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | |!| | |}} | {{Family tree | | | | | | | | | | | | | | | | | | | | | | |!| | |}} | ||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | |!| | |}} | {{Family tree | | | | | | | | | | | | | | | | | | | | | | |!| | |}} | ||
Line 178: | Line 200: | ||
{{Family tree | | | | | | | | | | |P09| | | |c09| | |l09| | |P09=[[Meningococcemia]]|c09=[[Rocky Mountain spotted fever]]|l09=[[Syphillis]]}} | {{Family tree | | | | | | | | | | |P09| | | |c09| | |l09| | |P09=[[Meningococcemia]]|c09=[[Rocky Mountain spotted fever]]|l09=[[Syphillis]]}} | ||
{{Family tree | | | | | | | | | | |!| | | | | | |!| |!| | | | | | |}} | {{Family tree | | | | | | | | | | |!| | | | | | |!| |!| | | | | | |}} | ||
{{Family tree | | | | | | | | | | |p09| | | | |P08| |u09| | | | | | | |u09=<div style="float: left; text-align: left; height: | {{Family tree | | | | | | | | | | |p09| | | | |P08| |u09| | | | | | | |u09=<div style="float: left; text-align: left; height: 32em; width: 14em; padding:1em;"> '''Characteristics:'''<br> | ||
---- | ---- | ||
❑ Caused by Treponema pallidum <br>❑Secondary syphilis may appear as rough, red, or reddish brown spots on the palms of the hands and the bottoms of the feet]<br/> ❑ Non-pruritic<br/> | ❑ Caused by [[Treponema pallidum]] <br><br/>❑Secondary [[syphilis]] may appear as rough, red, or reddish brown spots on the palms of the hands and the bottoms of the feet]<br/><br/> ❑ [[Non-pruritic]]<br/> <br/> ❑ [[Fever]] <br><br/> </div>|P08=<div style="float: left; text-align: left; height: 28em; width: 14em; padding:1em;"> '''Characteristics:'''<br> | ||
---- | ---- | ||
❑ Caused by Rickettsia rickettsii <br>❑ History of travel to wooden areas, primarily in the south-Atlantic region of the United States ❑[[Erythematous]] and [[maculopapular]] that initially begins on wrists and ankles, then spreads and becomes [[petechial]]<br/> | ❑ Caused by [[Rickettsia rickettsii]] <br><br/>❑ History of travel to wooden areas, primarily in the south-Atlantic region of the United States ❑ [[Erythematous]] and [[maculopapular]] that initially begins on wrists and ankles, then spreads and becomes [[petechial]]<br/><br/> ❑ Ill appearing patient, can be in [[shock]]<br/><br/> ❑ High [[fever]] <br><br/> </div>|p09=<div style="float: left; text-align: left; height: 32em; width: 14em; padding:1em;"> '''Characteristics:'''<br> | ||
---- | ---- | ||
❑ Infection with [[Neisseria meningitidis]] <br>❑ History of living in collge dormitory/millitary/prison ❑[[Erythematous]] and [[maculopapular]] that initially begins on wrists and ankles, then spreads and becomes [[petechial]]<br/> | ❑ Infection with [[Neisseria meningitidis]] <br><br/>❑ History of living in collge dormitory/millitary/prison<br/><br/> ❑[[Erythematous]] and [[maculopapular]] that initially begins on wrists and ankles, then spreads and becomes [[petechial]]<br/><br/> ❑ Ill appearing patient<br/><br/> ❑ [[Fever]] <br> </div>}} | ||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | |}} | {{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | |}} | {{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | |}} | {{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | |}} | {{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{Family tree/end}} | |||
If patient presents with [[Petechial]]/[[Purpuric]] rash:<ref name="Murphy-LavoieLeGros2018">{{cite journal|last1=Murphy-Lavoie|first1=Heather|last2=LeGros|first2=Tracy|title=The Algorithmic Approach to the Unidentified Rash|year=2018|pages=1–5|doi=10.1007/978-3-319-75623-3_1}}</ref> | |||
{{Family tree/start}} | |||
{{Family tree | | | | | | | A01 | | | |A01=[[Fever]] with [[Petechial]] rash/[[Perpuric]] rash}} | |||
{{Family tree | | | | | | | |!| | | | | }} | |||
{{Family tree | | | | | | | B01 | | | |B01= Palpate the [[rash]]}} | |||
{{Family tree | | | | | | | |!| | | | | }} | |||
{{Family tree | | | | | | | |!| | | | | }} | |||
{{Family tree | | | |,|-|-|-|^|-|-|-|-|-|-|-|-|-|-|-|-|-|.| }} | |||
{{Family tree | | | |!| | | | | | | | | | | | | | | | | |!}} | |||
{{Family tree | | | |C03| | | | | | | | | | | | | | | |C04| | | | | | | | | | | | | | |C03= Palpable|C04=Non-palpable}} | |||
{{Family tree | | | | | |!| | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}} | |||
{{Family tree | |,|-|-|-|+|-|-|-|v|-|-|-|-|v|-|-|-|.| | | | |!| | | | | | | | | |}} | |||
{{Family tree | |!| | | |!| | | |!| | | | |!| | | |!| | | | |!| | | | | | | | | | | |}} | |||
{{Family tree | |p09| |c09| |k09| |j09| |u09| | | |!| | | | | | |p09=[[Endocarditis]]|c09=[[Henoch-Schonlein purpura]]|k09=Disseminated | |||
gonococcal infection|j09=[[Rocky Mountain spotted fever]]|u09=[[Meningococcemia]]}} | |||
{{Family tree | |!| | | | |!| | | |!| | | | |!| | |!| | | | |!| | || | | | | | | | | | | | | |}} | |||
{{Family tree | |p09| | |c09| |s09| |u09| |q09| | |!| | |q09=<div style="float: left; text-align: left; height: 24em; width: 12em; padding:1em;"> '''Characteristics:'''<br> | |||
---- | |||
❑ Infection with [[Neisseria meningitidis]] <br><br/>❑ History of living in collge dormitory/millitary/prison<br/><br/> ❑[[Erythematous]] and [[maculopapular]] that initially begins on wrists and ankles, then spreads and becomes [[petechial]]<br/><br/> ❑ Ill appearing patient<br/><br/> ❑ [[Fever]] <br><br/> |u09=<div style="float: left; text-align: left; height: 24em; width: 12em; padding:1em;"> '''Characteristics:'''<br> | |||
---- | |||
❑ Caused by [[Rickettsia rickettsii]] <br><br/>❑ History of travel to wooden areas, primarily in the south-Atlantic region of the United States ❑ [[Erythematous]] and [[maculopapular]] that initially begins on wrists and ankles, then spreads and becomes [[petechial]]<br/><br/> ❑ Ill appearing patient, can be in [[shock]]<br/><br/> ❑ High [[fever]] <br><br/> </div> |s09=<div style="float: left; text-align: left; height: 24em; width: 12em; padding:1em;"> '''Characteristics:'''<br> | |||
---- | |||
❑ Caused by [[Neiserria Gonorrhoea]] <br><br/>❑ [[Rash]] maybe present in case of [[disseminated gonococcal infection]]. <br/><br/> ❑ Affects the trunk, limbs, palms and soles, and usually spare the face, scalp and mouth. <br><br/> </div> |c09=<div style="float: left; text-align: left; height: 39em; width: 12em; padding:1em;"> '''Characteristics:'''<br> | |||
---- | |||
❑ Autoimmune systemic [[vasculitis]] that affects the legs, buttocks, and arms and kidneys.<br/><br>❑ Usually preceded by an infection or drug exposure.<br/><br/> ❑ The classic triad comprises of [[purpura]], [[abdominal pain]], and [[arthritis]] in the knees, ankles, and elbows.<br/><br/> ❑ [[Pruritic]] <br><br/>❑ [[Nausea]] <br><br/>❑ [[Vomiting]] <br><br/>❑ [[Intussusception]] <br><br/>❑ [[Diarrhoea]]/[[Constipation]] </div> |p09=<div style="float: left; text-align: left; height: 28em; width: 12em; padding:1em;"> '''Characteristics:'''<ref name="GomesTiberto2016">{{cite journal|last1=Gomes|first1=Rafael Tomaz|last2=Tiberto|first2=Larissa Rezende|last3=Bello|first3=Viviane Nardin Monte|last4=Lima|first4=Margarete Aparecida Jacometo|last5=Nai|first5=Gisele Alborghetti|last6=Abreu|first6=Marilda Aparecida Milanez Morgado de|title=Dermatologic manifestations of infective endocarditis|journal=Anais Brasileiros de Dermatologia|volume=91|issue=5 suppl 1|year=2016|pages=92–94|issn=0365-0596|doi=10.1590/abd1806-4841.20164718}}</ref> | |||
<br> | |||
---- | |||
❑ History of IV drug use,[[Infective Endocarditis]], [[Rheumatic fever]]<br><br/>❑ Mostly caused by [[Staphylococcus]] and [[Streptococcus]]<br><br/> ❑ Look for [[Janeway lesion]]s which are painless purple or brown [[erythematous]] [[macular]] lesions, usually affects the [[palms]], soles, and fingers <br><br/> </div>}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | |,|-|-|-|-|-|-|-|-|-|-|-|-|^|.| | | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | |p09| | |l09| | | | |u09| | | | | | | | | | | | | | |p09=[[DIC]]|u09=[[Purpura | |||
fulminans]] |l09=[[TTP]] |}} | |||
{{Family tree | | | | | | | | | | |!| | | | |!| | | | | | | |!| | | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | |p09| | |s09| | | |u09| | | | | | | | | | | | |u09=<div style="float: left; text-align: left; height: 39em; width: 12em; padding:1em;"> '''Characteristics:'''<br> | |||
---- | |||
❑ Very ill patient<br/><br/> ❑ H/O previous infection most commonly by [[meningococcal]] or gram-negative organisms, [[pregnancy]], massive [[trauma]], end-stage [[Malignant|malignant disease]], [[hepatic failure]], snakebites, [[transfusion reactions]], and anything else that may precipitate [[DIC]]s<br/><br/> ❑ [[Fever]]<br/><br/> ❑ [[Shock]] <br/> ❑ Rapid subcutaneous [[hemorrhage]]<br/><br/> ❑ Widespread organ involvement<br><br/> </div> |s09=<div style="float: left; text-align: left; height: 29em; width: 12em; padding:1em;"> '''Characteristics:'''<ref name="urlThrombotic Thrombocytopenic Purpura | NHLBI, NIH">{{cite web |url=https://www.nhlbi.nih.gov/health-topics/thrombotic-thrombocytopenic-purpura |title=Thrombotic Thrombocytopenic Purpura | NHLBI, NIH |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref><br> | |||
---- | |||
❑ Purplish bruises or [[purpura]]/[[petechiae]] in the mouth<br/><br/> ❑ Yellowish color of the skin and sclera<br/><br/> ❑ [[Fatigue]]<br/><br/> ❑ [[Tachycardia]] <br><br/> ❑ [[Shortness of Breath]]|p09=<div style="float: left; text-align: left; height: 24em; width: 12em; padding:1em;"> '''Characteristics:'''<br> | |||
---- | |||
❑ Very ill patient.<br/><br/>❑ Complication of different serious and life-threatening diseases<br/><br/> ❑ Due to uncontrolled activation of clotting factors in the [[blood vessels]], causing [[Clot|clotting]] of blood in the whole body.<br/> ❑ Bleeding in other tissues.<br/><br> </div>}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree/end}} | |||
If patient presents with Vesiculo-bullous [[Rash]], follow the algoritm below:<ref name="Murphy-LavoieLeGros2018">{{cite journal|last1=Murphy-Lavoie|first1=Heather|last2=LeGros|first2=Tracy|title=The Algorithmic Approach to the Unidentified Rash|year=2018|pages=1–5|doi=10.1007/978-3-319-75623-3_1}}</ref> | |||
{{Family tree/start}} | |||
{{Family tree | | | | | | | A01 | | | |A01=[[Fever]] with [[Vesicobullous]] [[rash]]}} | |||
{{Family tree | | | | | | | |!| | | | | }} | |||
{{Family tree | | | | | | | B01 | | | |B01= Look at the rash and it's distribution}} | |||
{{Family tree | | | | | | | |!| | | | | }} | |||
{{Family tree | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | | | |,|-|-|-|^|-|-|-|-|-|-|-|-|-|-|-|-|-|-|-|-|-|.| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | | | |!| | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | |}} | |||
{{Family tree | | | |C03| | | | | | | | | | | | | | | | | | |C04| | | C03= Diffuse distribution with [[fever]]|C04=Localized distribution with [[fever]]}} | |||
{{Family tree | | | | | |!| | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}} | |||
{{Family tree | |,|-|-|-|+|-|-|-|v|-|-|-|-|-|-|-|-|-|.| | | | | |!| | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | |!| | | |!| | | |!| | | | | | | | | |!| | | | | |!| | | | | | | | | | | | | |}} | |||
{{Family tree | |p09| |u09| |l09| | | | | |y09| | | | | |!| | | | | | | | | | | | | | |p09=[[Varicella]]|l09=[[Disseminated gonococcal disease]]|u09=[[Purpura fulminans]]|y09=[[DIC]]}} | |||
{{Family tree | |!| | | | |!| | | |!| | | | | | |!| | | | | | | |!| | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | |p09| | |s09| |l09| | | |y09| | | | | | |!| | | | | | |y09=<div style="float: left; text-align: left; height: 30em; width: 12em; padding:1em;"> '''Characteristics:'''<br> | |||
---- | |||
❑ Very ill patient.<br/><br/> ❑ Complication of different serious and life-threatening diseases<br/><br/> ❑ Due to uncontrolled activation of [[Clotting factor|clotting factors]] in the [[blood vessels]], causing [[clotting]] of blood in the whole body<br/><br/> ❑ Bleeding in other tissues <br><br/> </div> |l09=<div style="float: left; text-align: left; height: 29em; width: 12em; padding:1em;"> '''Characteristics:'''<br> | |||
---- | |||
❑ Caused by [[Neiserria Gonorrhoea]] <br><br/>❑ [[Rash]] maybe present in case of [[disseminated gonococcal infection]]. <br/><br/> ❑ Affects the trunk, limbs, palms and soles, and usually spare the face, [[scalp]] and mouth. <br><br/> </div>|s09=<div style="float: left; text-align: left; height: 39em; width: 12em; padding:1em;"> '''Characteristics:'''<br> | |||
---- | |||
❑ Very ill patient<br/><br/> ❑ H/O previous infection most commonly by [[meningococcal]] or [[Gram negative bacteria|gram-negative organisms]], pregnancy, massive [[trauma]], end-stage [[malignant]] disease, [[hepatic failure]], snakebites, [[transfusion reactions]], and anything else that may precipitate [[DIC]]s<br/><br/> ❑ [[Fever]]<br/><br/> ❑ [[Shock]] <br/><br/> ❑ Rapid subcutaneous [[hemorrhage]]<br/><br/> ❑ Widespread organ involvement<br> </div> |p09=<div style="float: left; text-align: left; height: 32em; width: 12em; padding:1em;"> '''Characteristics:'''<ref name="urlChickenpox | For Healthcare Professionals | Varicella | CDC">{{cite web |url=https://www.cdc.gov/chickenpox/hcp/index.html |title=Chickenpox | For Healthcare Professionals | Varicella | CDC |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref><br> | |||
---- | |||
❑ It is caused by [[varicella-zoster virus]] (VZV).<br/><br/> ❑ [[Temperature]] up to 102°F.<br/> ❑ [[Rash]] is generalized and [[Pruritis|pruritic]],usually starts from [[chest]], [[back]], and face, then spreads over the entire body.<br/><br/> ❑ Rash progresses rapidly from [[macular]] to [[Papule|papular]] to [[vesicular]] lesions before crusting.<br/><br/> ❑ [[Malaise]]<br/><br/> </div> | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | |,|-|-|-|-|-|-|-|^|.| | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | |!| | | | | | | | |!| | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | |u09| | | | | | |p09 | | | | | | | | | | |u09=[[Necrotizing fasciitis]] |p09=[[Hand-foot-and-mouth disease]] | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | |!| | | | | | | |!| | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | |u09| | | | | |t09| | | | | | | |t09=<div style="float: left; text-align: left; height: 28em; width: 12em; padding:1em;"> '''Characteristics:'''<br> | |||
---- | |||
❑ Mainly seen in young children, caused by [[enterovirus]] <br><br/>❑ Symmetrical [[vesicles]] mainly hands, feet and mouth <br/><br/> ❑ Can extend to limbs and buttocks <br><br/> </div> |u09=<div style="float: left; text-align: left; height: 24em; width: 12em; padding:1em;"> '''Characteristics:'''<br> | |||
---- | |||
❑ Very sick patient, may be in [[septic shock]] <br><br/>❑ Rapid spread of [[cellulitis]] with [[purpura]]/[[blister|blistering]], [[genitalia]] may be involved <br/><br/> ❑ Affected area may have decreased sensation<br><br/> </div> | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree/end}} | |||
Patient comes with [[Erythematous]] [[rash]], follow the algorithm below:<ref name="Murphy-LavoieLeGros2018">{{cite journal|last1=Murphy-Lavoie|first1=Heather|last2=LeGros|first2=Tracy|title=The Algorithmic Approach to the Unidentified Rash|year=2018|pages=1–5|doi=10.1007/978-3-319-75623-3_1}}</ref> | |||
{{Family tree/start}} | |||
{{Family tree | | | | | | | A01 | | | |A01=[[Fever]] with [[Erythematous]] rash}} | |||
{{Family tree | | | | | | | |!| | | | | }} | |||
{{Family tree | | | | | | | B01 | | | |B01= Look for [[Nikolsky's sign|Nikolsky sign]]}} | |||
{{Family tree | | | | | | | |!| | | | | }} | |||
{{Family tree | | | | | | | |!| | | | | }} | |||
{{Family tree | | | |,|-|-|-|^|-|-|-|-|-|-|-|-|-|-|-|-|-|.| }} | |||
{{Family tree | | | |!| | | | | | | | | | | | | | | | | |!}} | |||
{{Family tree | | | |C03| | | | | | | | | | | | | | | |C04| | | | | | | | | | | | | | |C03= Present|C04=Absent}} | |||
{{Family tree | | | | |!| | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | |,|-|-|^|-|-|-|-|.| | | | | | | |,|-|-|-|+|-|-|-|-|.| | | | | | | | | | | | | | |}} | |||
{{Family tree | |!| | | | | | | |!| | | | | | | |!| | | |!| | | | |!| | | | | | | | | | | | | |}} | |||
{{Family tree | |u09| | | | | |t09| | | | |q09| |w09| | |e09| | | | |q09=[[Kawasaki disease]]|w09=[[Scarlet fever]] |e09=[[Toxic Shock Syndrome]] | | |u09=[[Scalded-skin syndrome|Staphylococcal Scalded Skin Syndrome]]:|t09=[[Toxic Epidermal Necrolysis]]| | | | | | |}} | |||
{{Family tree | | |!| | | | | | |!| | | | | | | |!| | | | |!| | |!| | | | | | | | | | | | | | |}} | |||
{{Family tree | |u09| | | | |t09| | | | | |p09| |q09| | |s09| | | | | | | |p09=<div style="float: left; text-align: left; height: 39em; width: 12em; padding:1em;"> '''Characteristics:'''<br> | |||
---- | |||
❑ Mainly seen in young children,[[vasculitis]] due to [[autoimmune]] or [[infective]] cause<br>❑Affects many systems, including the skin, mucous membranes, [[lymphatics]], and [[blood vessels]]. <br/><br/> ❑ High fever for at least 5 days.<br/><br/> ❑ Diffuse [[erythroderma]] <br/> ❑[[Strawberry tongue]] <br/><br/> ❑ Significant [[cervical]] [[lymphadenopathy]] <br/><br/> ❑ [[Conjunctival injection]], peeling of the fingers and toes<br/> <br/> ❑[ [Oedema]] of the extremities <br><br/> </div> |q09=<div style="float: left; text-align: left; height: 29em; width: 12em; padding:1em;"> '''Characteristics:'''<br> | |||
---- | |||
❑ [[Strawberry tongue]]<br><br/>❑ Tiny red [[macules]] or rough [[papules]] <br/><br/> ❑ Swollen then peeling hands<br><br/>❑ Evidence of [[streptococcal infection]]<br><br/> </div> |s09=<div style="float: left; text-align: left; height: 32em; width: 12em; padding:1em;"> '''Characteristics:'''<br> | |||
---- | |||
❑ Associated with tampon use in female,[[abscesses]], nasal packing, surgical wounds, and [[postpartum]] conditions<br><br/>❑ Patient is [[toxic]], in [[shock]], and [[febrile]]<br/><br/> ❑ Diffuse [[erythematous]] [[rash]] that eventually leads to [[desquamation]] of the hands and feet.<br/><br/> </div> | |u09=<div style="float: left; text-align: left; height: 29em; width: 12em; padding:1em;"> '''Characteristics:'''<br> | |||
---- | |||
❑ Mainly seen in young children,usually less than 5 years of age.<br><br/>❑ Sudden onset of [[Fever|fever.]] <br/><br/> ❑[[Erythema]] of the neck, [[axilla]], and [[groin]], and extreme skin tenderness <br><br>❑[[Mucous membrane]] not included<br><br/>❑ Shallow skin cleavage plane </div> |t09=<div style="float: left; text-align: left; height: 45 em; width: 14em; padding:1em;"> '''Characteristics:'''<br> | |||
---- | |||
❑ Caused by drug reaction and most commonly associated with [[sulfa drugs]]. Other drugs include [[anticonvulsants]], [[antivirals]], [[NSAIDs]], and [[allopurinol]]. <br><br/>❑ Sudden-onset diffuse [[erythema]] with tender skin and sloughing.<br/><br/> ❑ [[Rash]] starts from the face and around the eyes, then spread to whole body.<br/><br/> ❑ Massive skin sloughing in large sheets <br><br/> ❑ Patient is [[toxic]] <br/><br/> ❑ [[Myalgia]]<br/><br/> ❑ [[Mucous membrane]] is involved.<br/><br/> ❑ [[Immunocompromised]] patients,[[HIV]] patients, patient with [[SLE]],[[brain tumor]] are the high risk population.<br/><br/></div> | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree/end}} | {{Family tree/end}} | ||
==Treatment== | ==Treatment== | ||
Shown below is an algorithm summarizing the treatment of <nowiki>[[disease | Shown below is an algorithm summarizing the treatment of [[rash]] with [[fever]]<ref name="Murphy-LavoieLeGros2018">{{cite journal|last1=Murphy-Lavoie|first1=Heather|last2=LeGros|first2=Tracy|title=The Algorithmic Approach to the Unidentified Rash|year=2018|pages=1–5|doi=10.1007/978-3-319-75623-3_1}}</ref><ref name="pmid19222477">{{cite journal |vauthors=Levi M, Toh CH, Thachil J, Watson HG |title=Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology |journal=Br. J. Haematol. |volume=145 |issue=1 |pages=24–33 |date=April 2009 |pmid=19222477 |doi=10.1111/j.1365-2141.2009.07600.x |url= |issn=}}</ref><ref name="pmid27406461">{{cite journal |vauthors=Lohani S, Nazir S, Tachamo N, Patel N |title=Disseminated gonococcal infection: an unusual presentation |journal=J Community Hosp Intern Med Perspect |volume=6 |issue=3 |pages=31841 |date=2016 |pmid=27406461 |pmc=4942509 |doi=10.3402/jchimp.v6.31841 |url= |issn=}}</ref><ref name="pmid25593960">{{cite journal |vauthors=Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, Kanavidis P, Machairas A |title=Current concepts in the management of necrotizing fasciitis |journal=Front Surg |volume=1 |issue= |pages=36 |date=2014 |pmid=25593960 |pmc=4286984 |doi=10.3389/fsurg.2014.00036 |url= |issn=}}</ref><ref name="urlClinical Practice Guidelines : Kawasaki disease">{{cite web |url=https://www.rch.org.au/clinicalguide/guideline_index/Kawasaki_disease/ |title=Clinical Practice Guidelines : Kawasaki disease |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | ||
{{ | |||
{{ | If patient comes it maculopapular [[rash]] and [[fever]]: | ||
{{ | |||
{{ | <span style="font-size:85%">'''Abbreviations:''' '''HIV'''=[[Human Immunodeficiency Virus (HIV)|Human immunodeficiency Virus]], '''EM major'''=[[Erythema multiforme|Erythema Multiforme Major]], '''EM minor'''=[[Erythema Multiforme]] Minor, '''H/O'''=History of, '''DIC'''=[[disseminated intravascular coagulation]], '''VZV'''=[[Varicella zoster virus]],'''SLE'''=[[Systemic lupus erythematosus]], [[Thrombotic Thrombocytopenic Purpura|TTP=Thrombotic Thrombocytopenic Purpura]] ,RMSF= [[Rocky Mountain spotted fever|Rocky Mountain spotted feve]]<nowiki/>r, '''IM'''=Intramuscular, '''IVIG'''= [[Intravenous immunoglobulin|Intravenous Immunoglobulin]] | ||
{{ | |||
{{ | |||
{{ | {{Family tree/start}} | ||
{{ | {{Family tree | | | | | | | A01 | | | |A01=[[Fever]] with [[maculopapular]] rash}} | ||
{{ | {{Family tree | | | | | | | |!| | | | | }} | ||
{{ | {{Family tree | | | | | |,|-|-|-|v|-|-|-|-|-|-|-|-|v|-|-|-|-|-|-|v|-|-|-|-|v|-|-|-|.| | | || |}} | ||
{{ | {{Family tree | | | | | |p09| |o09| | | | | | |l09| | | |P09| | | |c09| |l09| | |P09=[[Meningococcemia]]|c09=[[Rocky Mountain spotted fever]]|l09=[[Lyme disease]] |p09=[[Stevens-Johnson Syndrome]]|o09=[[Erythema Multiforme]]}} | ||
{{ | {{Family tree | | | | | |!| | | | |!| | | | | | | |!| | | | | | | |!| | | | |!| | |!| |}} | ||
{{ | {{Family tree | | | | | |P08| | |P09| | | | | |p07| | | | |a01| | | |b01| |c01| |c01=<div style="float: left; text-align: left; height: 32em; width: 10em; padding:1em;"> '''Treatment:'''<br> | ||
---- | |||
❑ [[Doxycycline]] is the first-line treatment in nonpregnant adult patients <br><br/> ❑ Children can be treated with amoxicillin.<br/><br/> </div> |b01=<div style="float: left; text-align: left; height: 32em; width: 10em; padding:1em;"> '''Treatment:'''<br> | |||
---- | |||
❑ [[Doxycycline]] is the drug of choice in all nonpregnant patients and children.<br><br/> ❑ Pregnant patients can be treated with [[chloramphenicol]] <br/><br/> </div> |a01=<div style="float: left; text-align: left; height: 32em; width: 10em; padding:1em;"> '''Treatment:'''<br> | |||
---- | |||
❑ [[Ceftriaxone]] is first-line therapy. [[Vancomycin]] should be added. <br><br/> ❑ [[Rifampin]] is used as prophylaxis in close contacts of the patients, alternatively single-dose [[ciprofloxacin]] and IM [[ceftriaxone]] can be administered<.br/><br/> ❑ [[Dexamethasone]] can reduce neurologic sequelae if given early, even before administering [[antibiotics]].<br/><br/> </div> |P08=<div style="float: left; text-align: left; height: 32em; width: 10em; padding:1em;"> '''Treatment:'''<br> | |||
---- | |||
❑ Discontinuation of the offending agent <br><br/> ❑ Optimizing fluid and electrolyte levels <br/><br/> ❑ Admit to ICU<br/><br/> </div>|P09=<div style="float: left; text-align: left; height: 69em; width: 10em; padding:1em;"> '''Treatment:'''<br> | |||
---- | |||
❑ Mild cases (EM minor) require only symptomatic support <br/><br> ❑ Give [[analgesics]], cold compressions, topical [[steroid]]s.<br/><br/>❑ Treatment of the specific cause if it is found and dermatological followup visit should be scheduled.<br/><br/> ❑ In [[Erythema major]] more aggressive care is needed, start with discontinuation of the causative agent.<br/><br/> ❑ [[Fluid]] and electrolyte balance, [[analgesics]] for pain.<br/><br/> ❑ Clean the wounded area, Silver sulfadiazine should not be used.<br><br/> ❑ If oral lesions are present, soothing solution can be used.<br/><br> ❑ [[Steroid]] use may give rise to further complications than benefit.<br> ❑ Dermatological and [[ophthalmologic]] consultation is needed if eyes are involved.</div>|p07=<div style="float: left; text-align: left; height: 32em; width: 10em; padding:1em;"> '''Treatment:'''<br> | |||
---- | |||
❑ [[Doxycycline]] is the first-line treatment in non-pregnant adult patients.<br/><br> ❑ [[Amoxicillin]] can be used in children. </div>}} | |||
{{Family tree/end}} | |||
If patient comes with [[Petechial]]/[[Purpuric]] rash | |||
{{Family tree/start}} | |||
{{Family tree | | | | | | | A01 | | | |A01=[[Fever]] with [[Petechial]] rash/[[Perpuric]] rash}} | |||
{{Family tree | | | | | | | |!| | | | | }} | |||
{{Family tree | |,|-|-|-|-|v|^|-|v|-|-|-|-|v|-|-|-|v|-|-|-|-|v|-|-|v|-|-|-|.| | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | |!| | | | |!| | |!| | | | |!| | | |!| |!| | |!| | |!| | | |!| | |}} | |||
{{Family tree | |p09| |c09| |k09| |j09| |u09| | |a01| |b01| |c01| | | | | | | | | | | | | | |a01=[[DIC]]|b01=Purpura | |||
fulminans |c01=[[TTP]] | |p09=[[Endocarditis]]|c09=[[Henoch-Schonlein purpura]]|k09=Disseminated | |||
gonococcal infection|j09=[[Rocky Mountain spotted fever]]|u09=[[Meningococcemia]]}} | |||
{{Family tree | |!| | | | |!| | | |!| | | | |!| | |!| | | | | |!| | |!| | |!| | | | | | | | |}} | |||
{{Family tree | |p09| | |c09| |s09| |u09| |q09| | |a01| |b01| | |c01| |a01=<div style="float: left; text-align: left; height: 56em; width: 12em; padding:1em;"> '''Treatment:'''<ref name="pmid19222477">{{cite journal |vauthors=Levi M, Toh CH, Thachil J, Watson HG |title=Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology |journal=Br. J. Haematol. |volume=145 |issue=1 |pages=24–33 |date=April 2009 |pmid=19222477 |doi=10.1111/j.1365-2141.2009.07600.x |url= |issn=}}</ref><br> | |||
---- | |||
❑ The primary treatment of DIC is treatment of the underlying condition <br><br/> ❑ In patients with [[DIC]] and bleeding or at high risk of bleeding and a [[platelet]] count of <50 x 10(9)/l transfusion of [[platelets]] should be considered but non-bleeding patients with [[DIC]], prophylactic [[platelet]] transfusion is not given unless there is a high risk of bleeding. <br><br/> ❑ [[Activated partial thromboplastin time]] (aPTT), administration of [[fresh frozen plasma]] (FFP) may be useful in [[DIC]] patients with prolonged [[prothrombin time]] (PT).<br/><br/>❑ In patients where [[FFP]] can not be used due to chances of fluid overload,[[factor concentrates]] can be used. <br><br/> ❑ Patients with [[DIC]] with a primary [[hyper-fibrinolytic]] state and severe bleeding can be treated with [[lysine]] analogues, such as [[Tranexamic acid]], '''1 g every 8 hourly''' is administered. </div> |b01=<div style="float: left; text-align: left; height: 28em; width: 12em; padding:1em;"> '''Treatment:'''<br> | |||
---- | |||
❑ Admit to [[ICU]] immediately and hematology consultaion is needed. <br><br/>❑ First-line therapy is treatment of the underlying cause.<br/><br/>❑ [[Folate]], [[vitamin K]], [[fresh frozen plasma]] (FFP), [[cryoprecipitate]], [[platelets]], and red blood cell transfusions are given as needed; [[heparin]] can be used if there is any [[thrombi]].<br/><br/> </div>|c01=<div style="float: left; text-align: left; height: 28em; width: 12em; padding:1em;"> '''Treatment:'''<br> | |||
---- | |||
❑ Immediate hematology/oncology consultation.<br/><br>❑ Treatment of the underlying cause is done,[[Plasmapheresis]], [[FFP]] are used.<br/><br/>❑ [[Platelets]] should not be given as it will precipitate additional [[thrombus]] formation.<br/><br/> </div> |q09=<div style="float: left; text-align: left; height: 24em; width: 12em; padding:1em;"> '''Treatment:'''<br> | |||
---- | |||
❑ [[Ceftriaxone]] is first-line therapy. [[Vancomycin]] should be added <br><br/> ❑ [[Rifampin]] is used as prophylaxis in close contacts of the patients, alternatively single-dose [[ciprofloxacin]] and IM [[ceftriaxone]] can be administered.<br/><br/>❑ [[Dexamethasone]] can reduce neurologic sequelae if given early, even before administering [[antibiotics]].<br/><br/> </div> <br> |u09=<div style="float: left; text-align: left; height: 24em; width: 12em; padding:1em;"> '''Treatment:'''<br> | |||
---- | |||
❑ [[Doxycycline]] is the drug of choice in all non-pregnant patients and children.<br/><br> ❑ [[Pregnant]] patients can be treated with [[chloramphenicol]]. <br/><br/> </div> |s09=<div style="float: left; text-align: left; height: 24em; width: 12em; padding:1em;"> '''Treatment:'''<ref name="pmid27406461">{{cite journal |vauthors=Lohani S, Nazir S, Tachamo N, Patel N |title=Disseminated gonococcal infection: an unusual presentation |journal=J Community Hosp Intern Med Perspect |volume=6 |issue=3 |pages=31841 |date=2016 |pmid=27406461 |pmc=4942509 |doi=10.3402/jchimp.v6.31841 |url= |issn=}}</ref><br> | |||
---- | |||
❑ Patients with [[Disseminated gonococcal infection]] should be treated for at least 1 week with IV ceftriaxone. <br/><br/> ❑ Treatment duration should be extended in patients who do not improve adequately.<br/><br> </div> |c09=<div style="float: left; text-align: left; height: 28em; width: 12em; padding:1em;"> '''Treatment:'''<br> | |||
---- | |||
❑ Only supportive care.<br/><br>❑ Some patients need hospitalization for [[pain]] control, kidney [[biopsy]], and/or administration of [[Immunosuppressant|immunosuppressant agents]] or, occasionally, [[IVIG]].<br/> </div> |p09=<div style="float: left; text-align: left; height: 30em; width: 12em; padding:1em;"> '''Treatment:''' | |||
<br> | |||
---- | |||
❑ Initial empiric therapy is [[Vancomycin]] or [[Ampicillin]]/[[Sulbactam]] plus an [[Aminoglycoside]].<br/><br>❑[[Rifampin]] is added in patients with [[prosthetic valves]].<br><br/> ❑ [[Valve]] replacement should be considered in selected patients with [[infectious endocarditis]]. <br><br> ❑ [[Antimicrobial]] prophylaxis before certain [[dental]] and other procedures. </div>}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree/end}} | |||
If patient presents with [[Vesiculo-bullous]] [[Rash]], follow the algoritm below: | |||
{{Family tree/start}} | |||
{{Family tree | | | | | | | A01 | | | |A01=[[Fever]] with [[Vesicobullous]] [[rash]]}} | |||
{{Family tree | | | | | | | |!| | | | | }} | |||
{{Family tree | |,|-|-|-|-|-|^|-|-|.| | | | | | | | | | | | |}} | |||
{{Family tree | |!| | | | | | | | |!| | | | | | | | | | | |}} | |||
{{Family tree | |u09| | | | | | |p09| | | | | | | | | | |u09=[[Necrotizing fasciitis]] |p09=[[Hand-foot-and-mouth disease]] | |}} | |||
{{Family tree | |!| | | | | | | | |!| | | | | | | | | | | |}} | |||
{{Family tree | |u09| | | | | |t09| | | | | | | |t09=<div style="float: left; text-align: left; height: 24em; width: 12em; padding:1em;"> '''Treatment:'''<br> | |||
---- | |||
❑ Maintain hydration.<br/><br>❑ Treat the fever, avoid [[Aspirin]] to prevent [[Reye's syndrome]] in children.<br/> <br/> ❑ Alleviate pain from mouth [[Sore|sores]].<br/> <br> </div> |u09=<div style="float: left; text-align: left; height: 62em; width: 12em; padding:1em;"> '''Treatment:<ref name="pmid25593960">{{cite journal |vauthors=Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, Kanavidis P, Machairas A |title=Current concepts in the management of necrotizing fasciitis |journal=Front Surg |volume=1 |issue= |pages=36 |date=2014 |pmid=25593960 |pmc=4286984 |doi=10.3389/fsurg.2014.00036 |url= |issn=}}</ref>'''<br> | |||
---- | |||
❑ Emergency surgical [[debridement]] of the affected tissues is the primary management.<br/><br/> ❑ Initial [[antibiotic]] treatment includes [[Ampicillin]] or [[Ampicillin/Sulbactam|ampicillin–sulbactam]] combined with [[Metronidazole]] or [[Clindamycin]].<br/><br>❑ [[Metronidazole]], clindamycin, or carbapenems are used for anarobic coverage. <br/><br/> ❑ [[Ampicillin/sulbactam|Ampicillin–sulbactam]], [[Piperacillin/ Tazobactam|piperacillin–tazobactam]], [[Ticarcillin]]–[[Clavulanate acid]], third or fourth generation [[Cephalosporins]], or [[Carbapenems]] are used at a higher dosage if patient was recently admitted to hospital or were treated with [[antibiotics]].<br/> <br/> ❑ [[Antibiotic]] should be continued for 4–6 weeks and up to 5 days after local signs and symptoms have resolved.<br/><br/> ❑ Intravenous [[immunoglobulin]] (IVIG) can be used for neutralizing [[Streptococcal|streptococcal toxins]]. </div> | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree/end}} | |||
Patient comes with [[Erythematous]] [[rash]], follow the algorithm below: | |||
{{Family tree/start}} | |||
{{Family tree | | | | | | | A01 | | | |A01=[[Fever]] with [[Erythematous]] rash}} | |||
{{Family tree | | | | | | | |!| | | | | }} | |||
{{Family tree | |,|-|-|-|-|-|^|-|v|-|-|-|-|-|-|v|-|-|-|v|-|-|-|-|.| | | | | | | | | | | | | | |}} | |||
{{Family tree | |!| | | | | | | |!| | | | | | |!| | | |!| | | | |!| | | | | | | | | | | | | |}} | |||
{{Family tree | |u09| | | | | |t09| | | | |q09| |w09| | |e09| | | | |q09=[[Kawasaki disease]]|w09=[[Scarlet fever]] |e09=[[Toxic Shock Syndrome]] | | |u09=[[Scalded-skin syndrome|Staphylococcal Scalded Skin Syndrome]]:|t09=[[Toxic Epidermal Necrolysis]]| | | | | | |}} | |||
{{Family tree | | |!| | | | | | |!| | | | | | | |!| | | | |!| | |!| | | | | | | | | | | | | | |}} | |||
{{Family tree | |u09| | | | |t09| | | | | |p09| |q09| | |s09| | | | | | | |p09=<div style="float: left; text-align: left; height: 32em; width: 12em; padding:1em;"> '''Treatement:'''<br> | |||
---- | |||
❑ High dose [[aspirin]]<br><br/>❑ Hospitalization with supportive care.<br/><br/> ❑ [[IVIG]] <br/><br/> </div> |q09=<div style="float: left; text-align: left; height: 24em; width: 12em; padding:1em;"> '''Treatment:<ref name="urlClinical Practice Guidelines : Kawasaki disease">{{cite web |url=https://www.rch.org.au/clinicalguide/guideline_index/Kawasaki_disease/ |title=Clinical Practice Guidelines : Kawasaki disease |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref>'''<br> | |||
---- | |||
❑ [[IVIG]], 2g/kg as a single IV infusion on diagnosis, within the first 10 days of the illness.<br><br/>❑ Aspirin is given | |||
3-5mg/kg as a daily dose until normal echo on follow up(6 months). <br/> <br/> </div> |s09=<div style="float: left; text-align: left; height: 32em; width: 12em; padding:1em;"> '''Treatment:'''<br> | |||
---- | |||
❑ Removal of the infective material. <br/><br>❑ Administration of IV [[antibiotics]].<br/><br/> ❑ Fluid resuscitation.<br/><br/> ❑ [[IVIG]].<br/> <br/> ❑ Admit to ICU. </div> | |u09=<div style="float: left; text-align: left; height: 24em; width: 12em; padding:1em;"> '''Treatment:'''<br> | |||
---- | |||
❑ Treatment includes antistaphylococcal [[antibiotics]]<br/><br>❑ Fluid and electrolyte management, and local wound care.<br/> <br/> </div> |t09=<div style="float: left; text-align: left; height: 38 em; width: 14em; padding:1em;"> '''Treatment:'''<br> | |||
---- | |||
❑ Discontinuation of the offending agent <br/><br/> ❑ Fluid and electrolyte balance<br/><br/> ❑ [[IVIG|Intravenous immune globulin]] (IVIG) may be helpful. <br><br/> ❑ [[Sulfadiazine]] should not be used for wound care, as sulfa is the most common offending agent.<br/><br/> ❑ Clean the wound and [[ophthalmologic]] consultation if eyes are involved.<br/> </div> | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree/end}} | |||
==Do's== | ==Do's== | ||
* | |||
*If patient started any new medication,immediately should stop taking it. | |||
*If allergic to any known product/medication/food, stop taking it. | |||
==Don'ts== | ==Don'ts== | ||
* Don’t use rubbing alcohol on skin | |||
*Don’t use rubbing alcohol on skin | |||
*Don't clean open wounds with hydrogen peroxide or bleach | *Don't clean open wounds with hydrogen peroxide or bleach | ||
*Don’t use a triple-antibiotic ointment | *Don’t use a triple-antibiotic ointment | ||
Line 217: | Line 459: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Resident survival guide]] | [[Category:Resident survival guide]] | ||
<references /> | <references /> |
Latest revision as of 10:02, 11 February 2021
Rash with fever Resident Survival Guide Microchapters |
---|
Overview |
Causes |
Diagnosis |
Treatment |
Do's |
Don'ts |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rinky Agnes Botleroo, M.B.B.S.
Synonyms and keywords: Approach to febrile rash, Approach to Rash
Overview
A patient with fever may often come with rash.There are several causes for rash in febrile patients.Rash caused by infectious agents may have mild to severe outcome,so it is very important to diagnose the cause and treat accordingly.There can be some non-infectious causes as well.To diagnose efficiently a complete history must be taken which includes history of recent travel, contact with animals, medications, and exposure to forests and other natural environments. Additionally, time of onset of symptoms and morphology, location, distribution of the rash are be helpful in the clinical diagnosis.The most common causes are Dengue hemorrhagic fever, Rocky Mountain spotted fever (RMSF), Scarlet fever, Toxic Epidermal Necrolysis (TEN),Stevens-Johnson Syndrome (SJS), Henoch-Schonlein Purpura (HSP), Kawasaki disease, Lyme disease, Endocarditis, Disseminated gonococcal infection,Autoimmune vasculitis, Systemic lupus erythematosus (SLE),Rheumatoid arthritis,Sjogren’s syndrome, Varicella, Necrotizing fasciitis, Rubella, Measles.Usually,skin rashes are nonspecific and self-limited.If it is caused by viral infections unlike bacterial infections, they do not respond to antibiotics, so treatment usually focuses on relieving symptoms.If it is caused by bacterial infection specific antibiotic is prescribed.The treatment of non-infectious rashes depend on the underlying cause.
Causes
Life Threatening Causes
Life-threatening causes of febrile rashes include conditions that may result in death or permanent disability within 24 hours if left untreated.[1]
- Meningococcemia or Meningoencephalitis
- Thrombotic Thrombocytopenic Purpura (TTP)
- Disseminated Intravascular Coagulation (DIC)
- Bacterial sepsis(Pneumococcal, Staphylococcal)
Common Causes
Common causes of rash with fever are given below :[1]
- Typhoid fever
- Dengue hemorrhagic fever
- Rocky Mountain spotted fever (RMSF)
- Scarlet fever
- Toxic Epidermal Necrolysis (TEN)
- Stevens-Johnson Syndrome (SJS)
- Henoch-Schonlein Purpura (HSP)
- Kawasaki disease
- Lyme disease
- Endocarditis
- Disseminated gonococcal infection
- Autoimmune vasculitis
- Varicella
- Necrotizing fasciitis
- Hand foot and mouth (HFM) disease
- Anaphylaxis
- Shingles
- Rubella
- Measles
Diagnosis
Shown below are 04 algorithms summarizing the diagnosis of Rash with fever in a patient:[2][1]
Abbreviations: BP: Blood pressure, RR=Respiratory rate, HR=Heart Rate, HIV=Human immunodeficiency Virus, EM major=Erythema Multiforme Major, EM minor=Erythema Multiforme Minor, H/O=History of, DIC=disseminated intravascular coagulation, VZV=Varicella zoster virus,SLE=Systemic lupus erythematosus, TTP=Thrombotic Thrombocytopenic Purpura ,RMSF= Rocky Mountain spotted fever, IM=Intramuscular, IVIG= Intravenous Immunoglobulin, IVDU -Intravenous Drug User
Patient with Fever and Rash | |||||||||||||||||||||||||||
Take complete history | |||||||||||||||||||||||||||
Record Vital signs: ❑ Measure the temperature | |||||||||||||||||||||||||||
Ask about associated symptoms: ❑ Vomiting ❑ Nausea ❑ Abdominal Pain ❑ Cough ❑ Sore throat ❑ Chest pain ❑ Arthralgia | |||||||||||||||||||||||||||
Ask about other medical history: ❑ Asplenia ❑ Malignancy ❑ Collagen vascular disease ❑ Any recent medications ❑ Valvular heart disease ❑ Chronic liver disease ❑ Solid organ or bone marrow transplantation ❑ Steroid use ❑ Chemotherapy related immune suppression | |||||||||||||||||||||||||||
Ask about recent Exposure: ❑ Communal living ❑ Tick exposure ❑ Dog exposure ❑ Salt water exposure ❑ Tampon use ❑ IVDU ❑ Trauma and Diabetes Mellitus ❑ Exposure to sexually transmitted disease, including risk factors for infection with human immunodeficiency virus (HIV) | |||||||||||||||||||||||||||
Ask about recent travel history: ❑ International Travel history ❑ Travel in wooded areas(Rocky Mountain spotted fever and tick-borne diseases are common) ❑ Recent camping history | |||||||||||||||||||||||||||
General Physical Examination: ❑ General appearance-Is the patient toxic? or normal appearance ❑ Look for new-onset heart murmur or nuchal rigidity ❑ Nuchal rigidity ❑ Palpate Lymph nodes for Generalized lymphadenopathy ❑ Conjunctival injection ❑ Look for Nikolsky sign:Sloughing of full-thickness skin with lateral pressure ❑ Look for any lesion on the back, buttocks, or perineum ❑ In diabetic patients check feet ❑ Palpate abdomen for hepatosplenomegaly | |||||||||||||||||||||||||||||||||||||||||
Characterize rash | |||||||||||||||||||||||||||||||||||||||||
Maculopapular rash | Petechial/Purpuric rash | Vesiculobullous rash | Erythematous rash | ||||||||||||||||||||||||||||||||||||||
Terminolgies used to diagnose Rashes[1]
Term | Clinical Features |
---|---|
Lesion | Single,Small affected area |
Rash | An eruption on the skin; more extensive than a single lesion |
Macule | Well circumscribed area of change without elevation |
Papule | Solid raised lesion ≤1 cm |
Petechia | Small red/brown macule ≤1 cm
that does not blanche |
Purpura | Hemorrhagic area > 3 mm that does not blanch |
If a patient present with fever with maculopapular rash then follow the algorithm given below:[2]
Fever with maculopapular rash | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Look at the rash and it's distribution | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Central distribution with fever | Peripheral distribution with fever | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑Viral exanthem ❑Lyme disease ❑Still disease | Look for target lesion | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Present | Absent | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stevens-Johnson Syndrome | Erythema Multiforme | Lyme disease | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Characteristics: ❑ Usually occurs due to drug reaction ❑ Diffusely distributed target lesions including the palms and soles ❑ Mucous membrane may be involved ❑ Toxic appearing patient ❑ Fever | Characteristics: ❑ Usually autoimmune ❑ May follow Herpes simplex, Mycoplasma, Fungal diseases or may occur due to drug exposure (sulfa drugs, anticonvulsants, antibiotics) ❑ Mucous membrane not involved in EM minor ❑ In EM major significant involvement of mucous membrane ❑ Nonspecific upper respiratory tract infection, moderate fever, general discomfort, cough, sore throat, vomiting, chest pain, diarrhoea may occur before the onset of rash ❑ Rash may be seen in the palms, soles, face, and extensor surfaces and eye involvement in 10% | Characteristics: ❑ Usually there is a history of travelling to wooden area ❑ Tick-borne illness is caused by Borrelia burgdorferi ❑ A big lesion with dark red border and central clearing known as Erythema migrans ❑ Migratory arthalgia ❑ Atrioventricular Nodal block ❑ Myalgia ❑ Fever ❑ Bells palsy ❑ Confusion ❑ Meningitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Meningococcemia | Rocky Mountain spotted fever | Syphillis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Characteristics: ❑ Infection with Neisseria meningitidis ❑ History of living in collge dormitory/millitary/prison ❑Erythematous and maculopapular that initially begins on wrists and ankles, then spreads and becomes petechial ❑ Ill appearing patient ❑ Fever | Characteristics: ❑ Caused by Rickettsia rickettsii ❑ History of travel to wooden areas, primarily in the south-Atlantic region of the United States ❑ Erythematous and maculopapular that initially begins on wrists and ankles, then spreads and becomes petechial ❑ Ill appearing patient, can be in shock ❑ High fever | Characteristics: ❑ Caused by Treponema pallidum ❑Secondary syphilis may appear as rough, red, or reddish brown spots on the palms of the hands and the bottoms of the feet] ❑ Non-pruritic ❑ Fever | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
If patient presents with Petechial/Purpuric rash:[2]
Fever with Petechial rash/Perpuric rash | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Palpate the rash | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Palpable | Non-palpable | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Endocarditis | Henoch-Schonlein purpura | Disseminated gonococcal infection | Rocky Mountain spotted fever | Meningococcemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Characteristics:[3]
❑ History of IV drug use,Infective Endocarditis, Rheumatic fever ❑ Mostly caused by Staphylococcus and Streptococcus ❑ Look for Janeway lesions which are painless purple or brown erythematous macular lesions, usually affects the palms, soles, and fingers | Characteristics: ❑ Autoimmune systemic vasculitis that affects the legs, buttocks, and arms and kidneys. ❑ Usually preceded by an infection or drug exposure. ❑ The classic triad comprises of purpura, abdominal pain, and arthritis in the knees, ankles, and elbows. ❑ Pruritic ❑ Nausea ❑ Vomiting ❑ Intussusception ❑ Diarrhoea/Constipation | Characteristics: ❑ Caused by Neiserria Gonorrhoea ❑ Rash maybe present in case of disseminated gonococcal infection. ❑ Affects the trunk, limbs, palms and soles, and usually spare the face, scalp and mouth. | Characteristics: ❑ Caused by Rickettsia rickettsii ❑ History of travel to wooden areas, primarily in the south-Atlantic region of the United States ❑ Erythematous and maculopapular that initially begins on wrists and ankles, then spreads and becomes petechial ❑ Ill appearing patient, can be in shock ❑ High fever | Characteristics: ❑ Infection with Neisseria meningitidis ❑ History of living in collge dormitory/millitary/prison ❑Erythematous and maculopapular that initially begins on wrists and ankles, then spreads and becomes petechial ❑ Ill appearing patient ❑ Fever | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DIC | TTP | [[Purpura fulminans]] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Characteristics: ❑ Very ill patient. ❑ Complication of different serious and life-threatening diseases ❑ Due to uncontrolled activation of clotting factors in the blood vessels, causing clotting of blood in the whole body. ❑ Bleeding in other tissues. | Characteristics:[4] ❑ Purplish bruises or purpura/petechiae in the mouth ❑ Yellowish color of the skin and sclera ❑ Fatigue ❑ Tachycardia ❑ Shortness of Breath | Characteristics: ❑ Very ill patient ❑ H/O previous infection most commonly by meningococcal or gram-negative organisms, pregnancy, massive trauma, end-stage malignant disease, hepatic failure, snakebites, transfusion reactions, and anything else that may precipitate DICs ❑ Fever ❑ Shock ❑ Rapid subcutaneous hemorrhage ❑ Widespread organ involvement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
If patient presents with Vesiculo-bullous Rash, follow the algoritm below:[2]
Fever with Vesicobullous rash | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Look at the rash and it's distribution | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diffuse distribution with fever | Localized distribution with fever | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Varicella | Purpura fulminans | Disseminated gonococcal disease | DIC | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Characteristics:[5] ❑ It is caused by varicella-zoster virus (VZV). ❑ Temperature up to 102°F. ❑ Rash is generalized and pruritic,usually starts from chest, back, and face, then spreads over the entire body. ❑ Rash progresses rapidly from macular to papular to vesicular lesions before crusting. ❑ Malaise | Characteristics: ❑ Very ill patient ❑ H/O previous infection most commonly by meningococcal or gram-negative organisms, pregnancy, massive trauma, end-stage malignant disease, hepatic failure, snakebites, transfusion reactions, and anything else that may precipitate DICs ❑ Fever ❑ Shock ❑ Rapid subcutaneous hemorrhage ❑ Widespread organ involvement | Characteristics: ❑ Caused by Neiserria Gonorrhoea ❑ Rash maybe present in case of disseminated gonococcal infection. ❑ Affects the trunk, limbs, palms and soles, and usually spare the face, scalp and mouth. | Characteristics: ❑ Very ill patient. ❑ Complication of different serious and life-threatening diseases ❑ Due to uncontrolled activation of clotting factors in the blood vessels, causing clotting of blood in the whole body ❑ Bleeding in other tissues | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Necrotizing fasciitis | Hand-foot-and-mouth disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Characteristics: ❑ Very sick patient, may be in septic shock ❑ Rapid spread of cellulitis with purpura/blistering, genitalia may be involved ❑ Affected area may have decreased sensation | Characteristics: ❑ Mainly seen in young children, caused by enterovirus ❑ Symmetrical vesicles mainly hands, feet and mouth ❑ Can extend to limbs and buttocks | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Patient comes with Erythematous rash, follow the algorithm below:[2]
Fever with Erythematous rash | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Look for Nikolsky sign | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Present | Absent | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Staphylococcal Scalded Skin Syndrome: | Toxic Epidermal Necrolysis | Kawasaki disease | Scarlet fever | Toxic Shock Syndrome | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Characteristics: ❑ Mainly seen in young children,usually less than 5 years of age. ❑ Sudden onset of fever. ❑Erythema of the neck, axilla, and groin, and extreme skin tenderness ❑Mucous membrane not included ❑ Shallow skin cleavage plane | Characteristics: ❑ Caused by drug reaction and most commonly associated with sulfa drugs. Other drugs include anticonvulsants, antivirals, NSAIDs, and allopurinol. ❑ Sudden-onset diffuse erythema with tender skin and sloughing. ❑ Rash starts from the face and around the eyes, then spread to whole body. ❑ Massive skin sloughing in large sheets ❑ Patient is toxic ❑ Myalgia ❑ Mucous membrane is involved. ❑ Immunocompromised patients,HIV patients, patient with SLE,brain tumor are the high risk population. | Characteristics: ❑ Mainly seen in young children,vasculitis due to autoimmune or infective cause ❑Affects many systems, including the skin, mucous membranes, lymphatics, and blood vessels. ❑ High fever for at least 5 days. ❑ Diffuse erythroderma ❑Strawberry tongue ❑ Significant cervical lymphadenopathy ❑ Conjunctival injection, peeling of the fingers and toes ❑[ [Oedema]] of the extremities | Characteristics: ❑ Strawberry tongue ❑ Tiny red macules or rough papules ❑ Swollen then peeling hands ❑ Evidence of streptococcal infection | Characteristics: ❑ Associated with tampon use in female,abscesses, nasal packing, surgical wounds, and postpartum conditions ❑ Patient is toxic, in shock, and febrile ❑ Diffuse erythematous rash that eventually leads to desquamation of the hands and feet. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Treatment
Shown below is an algorithm summarizing the treatment of rash with fever[2][6][7][8][9]
If patient comes it maculopapular rash and fever:
Abbreviations: HIV=Human immunodeficiency Virus, EM major=Erythema Multiforme Major, EM minor=Erythema Multiforme Minor, H/O=History of, DIC=disseminated intravascular coagulation, VZV=Varicella zoster virus,SLE=Systemic lupus erythematosus, TTP=Thrombotic Thrombocytopenic Purpura ,RMSF= Rocky Mountain spotted fever, IM=Intramuscular, IVIG= Intravenous Immunoglobulin
Fever with maculopapular rash | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stevens-Johnson Syndrome | Erythema Multiforme | Lyme disease | Meningococcemia | Rocky Mountain spotted fever | Lyme disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Treatment: ❑ Discontinuation of the offending agent ❑ Optimizing fluid and electrolyte levels ❑ Admit to ICU | Treatment: ❑ Mild cases (EM minor) require only symptomatic support ❑ Give analgesics, cold compressions, topical steroids. ❑ Treatment of the specific cause if it is found and dermatological followup visit should be scheduled. ❑ In Erythema major more aggressive care is needed, start with discontinuation of the causative agent. ❑ Fluid and electrolyte balance, analgesics for pain. ❑ Clean the wounded area, Silver sulfadiazine should not be used. ❑ If oral lesions are present, soothing solution can be used. ❑ Steroid use may give rise to further complications than benefit. ❑ Dermatological and ophthalmologic consultation is needed if eyes are involved. | Treatment: ❑ Doxycycline is the first-line treatment in non-pregnant adult patients. ❑ Amoxicillin can be used in children. | Treatment: ❑ Ceftriaxone is first-line therapy. Vancomycin should be added. ❑ Rifampin is used as prophylaxis in close contacts of the patients, alternatively single-dose ciprofloxacin and IM ceftriaxone can be administered<.br/> ❑ Dexamethasone can reduce neurologic sequelae if given early, even before administering antibiotics. | Treatment: ❑ Doxycycline is the drug of choice in all nonpregnant patients and children. ❑ Pregnant patients can be treated with chloramphenicol | Treatment: ❑ Doxycycline is the first-line treatment in nonpregnant adult patients ❑ Children can be treated with amoxicillin. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
If patient comes with Petechial/Purpuric rash
Fever with Petechial rash/Perpuric rash | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Endocarditis | Henoch-Schonlein purpura | Disseminated gonococcal infection | Rocky Mountain spotted fever | Meningococcemia | DIC | Purpura fulminans | TTP | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Treatment:
❑ Initial empiric therapy is Vancomycin or Ampicillin/Sulbactam plus an Aminoglycoside. ❑Rifampin is added in patients with prosthetic valves. ❑ Valve replacement should be considered in selected patients with infectious endocarditis. ❑ Antimicrobial prophylaxis before certain dental and other procedures. | Treatment: ❑ Only supportive care. ❑ Some patients need hospitalization for pain control, kidney biopsy, and/or administration of immunosuppressant agents or, occasionally, IVIG. | Treatment:[7] ❑ Patients with Disseminated gonococcal infection should be treated for at least 1 week with IV ceftriaxone. ❑ Treatment duration should be extended in patients who do not improve adequately. | Treatment: ❑ Doxycycline is the drug of choice in all non-pregnant patients and children. ❑ Pregnant patients can be treated with chloramphenicol. | Treatment: ❑ Ceftriaxone is first-line therapy. Vancomycin should be added ❑ Rifampin is used as prophylaxis in close contacts of the patients, alternatively single-dose ciprofloxacin and IM ceftriaxone can be administered. ❑ Dexamethasone can reduce neurologic sequelae if given early, even before administering antibiotics. | Treatment:[6] ❑ The primary treatment of DIC is treatment of the underlying condition ❑ In patients with DIC and bleeding or at high risk of bleeding and a platelet count of <50 x 10(9)/l transfusion of platelets should be considered but non-bleeding patients with DIC, prophylactic platelet transfusion is not given unless there is a high risk of bleeding. ❑ Activated partial thromboplastin time (aPTT), administration of fresh frozen plasma (FFP) may be useful in DIC patients with prolonged prothrombin time (PT). ❑ In patients where FFP can not be used due to chances of fluid overload,factor concentrates can be used. ❑ Patients with DIC with a primary hyper-fibrinolytic state and severe bleeding can be treated with lysine analogues, such as Tranexamic acid, 1 g every 8 hourly is administered. | Treatment: ❑ Admit to ICU immediately and hematology consultaion is needed. ❑ First-line therapy is treatment of the underlying cause. ❑ Folate, vitamin K, fresh frozen plasma (FFP), cryoprecipitate, platelets, and red blood cell transfusions are given as needed; heparin can be used if there is any thrombi. | Treatment: ❑ Immediate hematology/oncology consultation. ❑ Treatment of the underlying cause is done,Plasmapheresis, FFP are used. ❑ Platelets should not be given as it will precipitate additional thrombus formation. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
If patient presents with Vesiculo-bullous Rash, follow the algoritm below:
Fever with Vesicobullous rash | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Necrotizing fasciitis | Hand-foot-and-mouth disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Treatment:[8] ❑ Emergency surgical debridement of the affected tissues is the primary management. ❑ Initial antibiotic treatment includes Ampicillin or ampicillin–sulbactam combined with Metronidazole or Clindamycin. ❑ Metronidazole, clindamycin, or carbapenems are used for anarobic coverage. ❑ Ampicillin–sulbactam, piperacillin–tazobactam, Ticarcillin–Clavulanate acid, third or fourth generation Cephalosporins, or Carbapenems are used at a higher dosage if patient was recently admitted to hospital or were treated with antibiotics. ❑ Antibiotic should be continued for 4–6 weeks and up to 5 days after local signs and symptoms have resolved. ❑ Intravenous immunoglobulin (IVIG) can be used for neutralizing streptococcal toxins. | Treatment: ❑ Maintain hydration. ❑ Treat the fever, avoid Aspirin to prevent Reye's syndrome in children. ❑ Alleviate pain from mouth sores. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Patient comes with Erythematous rash, follow the algorithm below:
Fever with Erythematous rash | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Staphylococcal Scalded Skin Syndrome: | Toxic Epidermal Necrolysis | Kawasaki disease | Scarlet fever | Toxic Shock Syndrome | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Treatment: ❑ Treatment includes antistaphylococcal antibiotics ❑ Fluid and electrolyte management, and local wound care. | Treatment: ❑ Discontinuation of the offending agent ❑ Fluid and electrolyte balance ❑ Intravenous immune globulin (IVIG) may be helpful. ❑ Sulfadiazine should not be used for wound care, as sulfa is the most common offending agent. ❑ Clean the wound and ophthalmologic consultation if eyes are involved. | Treatment: ❑ Removal of the infective material. ❑ Administration of IV antibiotics. ❑ Fluid resuscitation. ❑ IVIG. ❑ Admit to ICU. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
- If patient started any new medication,immediately should stop taking it.
- If allergic to any known product/medication/food, stop taking it.
Don'ts
- Don’t use rubbing alcohol on skin
- Don't clean open wounds with hydrogen peroxide or bleach
- Don’t use a triple-antibiotic ointment
References
- ↑ 1.0 1.1 1.2 1.3 Kang JH (September 2015). "Febrile Illness with Skin Rashes". Infect Chemother. 47 (3): 155–66. doi:10.3947/ic.2015.47.3.155. PMC 4607768. PMID 26483989.
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 Murphy-Lavoie, Heather; LeGros, Tracy (2018). "The Algorithmic Approach to the Unidentified Rash": 1–5. doi:10.1007/978-3-319-75623-3_1.
- ↑ Gomes, Rafael Tomaz; Tiberto, Larissa Rezende; Bello, Viviane Nardin Monte; Lima, Margarete Aparecida Jacometo; Nai, Gisele Alborghetti; Abreu, Marilda Aparecida Milanez Morgado de (2016). "Dermatologic manifestations of infective endocarditis". Anais Brasileiros de Dermatologia. 91 (5 suppl 1): 92–94. doi:10.1590/abd1806-4841.20164718. ISSN 0365-0596.
- ↑ "Thrombotic Thrombocytopenic Purpura | NHLBI, NIH".
- ↑ "Chickenpox | For Healthcare Professionals | Varicella | CDC".
- ↑ 6.0 6.1 Levi M, Toh CH, Thachil J, Watson HG (April 2009). "Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology". Br. J. Haematol. 145 (1): 24–33. doi:10.1111/j.1365-2141.2009.07600.x. PMID 19222477.
- ↑ 7.0 7.1 Lohani S, Nazir S, Tachamo N, Patel N (2016). "Disseminated gonococcal infection: an unusual presentation". J Community Hosp Intern Med Perspect. 6 (3): 31841. doi:10.3402/jchimp.v6.31841. PMC 4942509. PMID 27406461.
- ↑ 8.0 8.1 Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, Kanavidis P, Machairas A (2014). "Current concepts in the management of necrotizing fasciitis". Front Surg. 1: 36. doi:10.3389/fsurg.2014.00036. PMC 4286984. PMID 25593960.
- ↑ 9.0 9.1 "Clinical Practice Guidelines : Kawasaki disease".